Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLRA1 | P23415 | 1/20 | 0.43 |
| ▸ | SLC6A9 | P48067 | 1/20 | 0.43 |
| ▸ | OR51E2 | Q9H255 | 1/20 | 0.43 |
| ▸ | TERT | O14746 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.38 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.38 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.37 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.36 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 0.36 |
| ▸ | FAAH | O00519 | 5/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | CTH | P32929 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL93766 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL391028 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL6674512 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL6674893 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL1402291 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL6130185 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| Glycylglycylglycine SCHEMBL98565 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL6677616 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL391787 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 | |
| SCHEMBL6120072 | 1.00 | GLRA1 (0.43) | GLRA1SLC6A9OR51E2TERTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 169 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1804835-A4 | MULTIMERIC CONSTRUCTS | GENZYME CORP (US) | 2008-07-30 | — | — | EP | claimed |
| US-20080058505-A1 | PTH functional domain conjugate peptides, derivatives thereof and novel tethered ligand-receptor molecules | GARDELLA THOMAS J | 2008-03-06 | — | — | US | claimed |
| EP-1804835-A2 | MULTIMERIC CONSTRUCTS | GENZYME CORPORATION (US) | 2007-07-11 | — | — | EP | claimed |
| EP-1615998-A4 | PLANT CELLS AND PLANTS WITH INCREASED TOLERANCE TO ENVIRONMENTAL STRESS | BASF PLANT SCIENCE GMBH (DE) | 2007-06-13 | — | — | EP | claimed |
| WO-2006031689-A2 | MULTIMERIC CONSTRUCTS | GENZYME CORPORATION (US) | 2006-03-23 | — | — | WO | claimed |
| EP-1615998-A2 | PLANT CELLS AND PLANTS WITH INCREASED TOLERANCE TO ENVIRONMENTAL STRESS | BASF Plant Science GmbH (DE) | 2006-01-18 | — | — | EP | claimed |
| WO-2004092349-A2 | PLANT CELLS AND PLANTS WITH INCREASED TOLERANCE TO ENVIRONMENTAL STRESS | BASF PLANT SCIENCE GMBH (DE) | 2004-10-28 | — | — | WO | claimed |
| EP-1147133-A4 | PTH FUNCTIONAL DOMAIN CONJUGATE PEPTIDES, DERIVATIVES THEREOF AND NOVEL TETHERED LIGAND-RECEPTOR MOLECULES | GEN HOSPITAL CORP (US) | 2003-02-12 | — | — | EP | claimed |
| EP-1147133-A2 | PTH FUNCTIONAL DOMAIN CONJUGATE PEPTIDES, DERIVATIVES THEREOF AND NOVEL TETHERED LIGAND-RECEPTOR MOLECULES | THE GENERAL HOSPITAL CORPORATION (US) | 2001-10-24 | — | — | EP | claimed |
| WO-2000039278-A2 | PTH FUNCTIONAL DOMAIN CONJUGATE PEPTIDES, DERIVATIVES THEREOF AND NOVEL TETHERED LIGAND-RECEPTOR MOLECULES | THE GENERAL HOSPITAL CORPORATION (US) | 2000-07-06 | — | — | WO | claimed |
| WO-2000011158-A1 | GENETICALLY MODIFIED AND DIABETIC NON-HUMAN ANIMAL | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2000-03-02 | — | — | WO | claimed |
| US-20250051404-A1 | FUSION PROTEINS FOR INHIBITING ANGIOGENESIS | ALLGENESIS BIOTHERAPEUTICS INC. (TW) | 2025-02-13 | — | — | US | disclosed |
| US-12152057-B2 | Fusion proteins for inhibiting angiogenesis | ALLGENESIS BIOTHERAPEUTICS INC. (TW) | 2024-11-26 | — | — | US | disclosed |
| CN-111050790-B | Combination therapy for the treatment of cancer by intravenous administration of recombinant MVA and antibodies | 巴法里安诺迪克有限公司 | 2024-07-12 | — | — | CN | disclosed |
| CN-117956903-A | Modified antimicrobial peptides | 唐纳德丹福斯植物科学中心 | 2024-04-30 | — | — | CN | disclosed |
| WO-1999003882-A2 | HUMAN LEUKOCYTE CALCIUM ACTIVATED POTASSIUM CHANNEL POLYPEPTIDE | ZENECA LIMITED (GB) | 1999-01-28 | — | — | WO | disclosed |
| EP-0851919-A1 | ANTISENSE OLIGONUCLEOTIDE CHEMOTHERAPY FOR BENIGN HYPERPLASIA OR CANCER OF THE PROSTATE | University of Massachusetts Worcester (US) | 1998-07-08 | — | — | EP | disclosed |
| WO-1998011139-A1 | SMALL AND INTERMEDIATE CONDUCTANCE, CALCIUM-ACTIVATED POTASSIUM CHANNELS AND USES THEREOF | OREGON HEALTH SCIENCES UNIVERSITY (US) | 1998-03-19 | — | — | WO | disclosed |
| CN-1162334-A | Genes encoding signal recognition particle of aspergillus niger | NOVO NORDISK BIOTECH INC (US) | 1997-10-15 | — | — | CN | disclosed |
| WO-1997011170-A1 | ANTISENSE OLIGONUCLEOTIDE CHEMOTHERAPY FOR BENIGN HYPERPLASIA OR CANCER OF THE PROSTATE | WORCESTER FOUNDATION FOR BIOMEDICAL RESEARCH (US) | 1997-03-27 | — | — | WO | disclosed |